Literature DB >> 4422006

Serum thyroid hormone and thyrotropin concentrations during thyroxine and triiodothyronine therapy.

M Saberi, R D Utiger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4422006     DOI： 10.1210/jcem-39-5-923

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  15 in total

1.  The pharmacodynamic equivalence of levothyroxine and liothyronine: a randomized, double blind, cross-over study in thyroidectomized patients.

Authors:  Francesco S Celi; Marina Zemskova; Joyce D Linderman; Nabeel I Babar; Monica C Skarulis; Gyorgy Csako; Robert Wesley; Rene Costello; Scott R Penzak; Frank Pucino
Journal:  Clin Endocrinol (Oxf)       Date:  2010-05       Impact factor: 3.478

2.  Pharmacokinetics of L-Triiodothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal.

Authors:  Benjamin Van Tassell; George F Wohlford; Joyce D Linderman; Sheila Smith; Sahzene Yavuz; Frank Pucino; Francesco S Celi
Journal:  Thyroid       Date:  2019-09-12       Impact factor: 6.568

3.  Thyroid hormone treatment to mend a broken heart.

Authors:  Irwin Klein; Sara Danzi
Journal:  J Clin Endocrinol Metab       Date:  2008-04       Impact factor: 5.958

4.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

5.  Thyroid hormone replacement.

Authors:  R Cygan; L Rucker
Journal:  West J Med       Date:  1983-08

Review 6.  Euthyroid hyperthyroxinemia.

Authors:  R Rajatanavin; L E Braverman
Journal:  J Endocrinol Invest       Date:  1983-12       Impact factor: 4.256

7.  Prevalence of thyroid antibodies in Shiraz, Iran, an area with iodine deficiency.

Authors:  A A Khaleeli
Journal:  Postgrad Med J       Date:  1981-01       Impact factor: 2.401

8.  Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of "inappropriate secretion of TSH".

Authors:  M C Gershengorn; B D Weintraub
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

9.  Twenty-four hour variations of triiodothyronine (T3) levels in patients who had thyroid ablation for thyroid cancer, receiving T3 as suppressive treatment.

Authors:  B Busnardo; M E Girelli; F Bui; G P Zanatta; M Cimitan
Journal:  J Endocrinol Invest       Date:  1980 Oct-Dec       Impact factor: 4.256

10.  Single-dose T3 administration: kinetics and effects on biochemical and physiological parameters.

Authors:  Jacqueline Jonklaas; Kenneth D Burman; Hong Wang; Keith R Latham
Journal:  Ther Drug Monit       Date:  2015-02       Impact factor: 3.681
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.